TrioBiotics Pharma AG

Triton Biopharma AG: Triton BioPharma lizensiert neuartigen natürlichen, antibakteriellen Wirkstoff gegen MRSA

Triton Biopharma AG: Marcus Tius joins International Research Team

Triton BioPharma commences Commercial Sale of Marine-Derived Fine Chemicals

Triton BioPharma AG launches new multimedia Web Station

Triton BioPharma to be profiled on CNBC Europe

Triton Biopharma AG: Michael Jarmolowich appointed as Board Member

Triton BioPharma establishes Fellowship Program

Triton BioPharma AG names Mark Hamann as Chief Scientific Officer

Triton BioPharma AG submits Grant Application to U.S. Department of Defense’s Congressionally Directed Medical Research Program regarding Traumatic Brain Injury Research

Triton Biopharma AG: Raymond Schinazi joins company as a Board Member

Triton BioPharma to be profiled in Business News segment for broadcast on CNBC Europe

Triton BioPharma Submits Product Development Application to U.S. Department of Defense’s Congressionally Directed Medical Research Program regarding Post-traumatic Stress Disorder Research

Triton Biopharma AG: Dr. Stephan Eschmann is appointed to the Board of Directors of Triton BioPharma A